70 likes | 185 Views
Presentation to:. FDA Conference Center, Silver Spring, MD 20993, August 25-26 2011. Experiences of the Swedish MRTP ─ Snus Elucidating some questions at this workshop by means of data from scientific studies (the FSI / ITS survey) * of the use in Sweden of
E N D
Presentationto: FDA Conference Center, Silver Spring, MD 20993, August 25-26 2011 Experiences of the Swedish MRTP ─ Snus Elucidating some questions at this workshop by means of data from scientific studies (the FSI / ITS survey)* of the use in Sweden of a specific MRTP ─ Snus ─ a low-toxicity oral tobacco product. *Postal survey conducted from January 2001 to February 2011 reaching a nationally representative sample of approximately 10.000 respondents during every year. The study is conducted in collaboration between the Research Group for Societal and Information Studies (FSI) and the Institute for Tobacco Studies (ITS). Lars M. Ramström PhD Director, Institute for Tobacco Studies Stockholm, Sweden Email: lars.ramstrom@tobaccostudies.com
Experiences of the Swedish MRTP — Snus What is the likelihood to start smoking for those who have started tobacco usage with Snus, the “primary snus users”? Source: FSI / ITS surveys 2003 - 2011
Experiences of the Swedish MRTP — Snus How does increasing initiation of Snus use influence total initiation of tobacco use?
Experiences of the Swedish MRTP — Snus What happens after smokers have taken up Snus use?
Experiences of the Swedish MRTP — Snus What is the overall association between Snus use and smoking cessation? Source: FSI / ITS surveys 2003 - 2011
Experiences of the Swedish MRTP — Snus What are the benefits of the use of Snus compared to products approved to treat nicotine dependence?
Experiences of the Swedish MRTP — Snus Do MRTPs like Swedish Snus use have a potential to achieve an overall public health benefit? Sweden has developed record-low levels of smoking and all tobacco-induced diseases. It has been shown that Snus use in Sweden has both decreased initiation of tobacco use and increased cessation of smoking. This means that the use of snus has achieved an overall public health benefit by serving as an important contributory factor for the favorable development in Sweden. Similar development should be possible in other countries, but only if prevailing knowledge gaps are filled and common misperceptions are corrected by appropriate public information.